Tiansheng Pharmaceutical Group Co., Ltd. (002872.SZ)
CNY 4.76
(-0.83%)
CNY 4.76
(-0.83%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -93.57 Million CNY | -82.76% |
| 2022 | -51.19 Million CNY | -685.57% |
| 2021 | -6.51 Million CNY | 93.19% |
| 2020 | -95.73 Million CNY | 6.74% |
| 2019 | -102.65 Million CNY | -206.24% |
| 2018 | 96.62 Million CNY | -68.79% |
| 2017 | 309.64 Million CNY | 29.74% |
| 2016 | 238.66 Million CNY | 15.34% |
| 2015 | 206.92 Million CNY | 19.37% |
| 2014 | 173.34 Million CNY | 15.84% |
| 2013 | 149.63 Million CNY | 38.97% |
| 2012 | 107.67 Million CNY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q3 | -11.4 Million CNY | 133.51% |
| 2024 Q1 | -25.27 Million CNY | -169.11% |
| 2024 Q2 | -24.61 Million CNY | 2.62% |
| 2023 Q1 | -15.77 Million CNY | 11.2% |
| 2023 FY | -93.57 Million CNY | -82.76% |
| 2023 Q2 | -39.38 Million CNY | -149.72% |
| 2023 Q3 | -29.02 Million CNY | 26.29% |
| 2023 Q4 | -9.39 Million CNY | 67.64% |
| 2022 Q4 | -17.75 Million CNY | 25.17% |
| 2022 FY | -51.19 Million CNY | -685.57% |
| 2022 Q3 | -23.73 Million CNY | 15.56% |
| 2022 Q2 | -28.1 Million CNY | -102.02% |
| 2022 Q1 | -13.91 Million CNY | -230.64% |
| 2021 Q1 | -24.77 Million CNY | 93.75% |
| 2021 Q4 | 10.64 Million CNY | 137.86% |
| 2021 Q2 | -18.74 Million CNY | 24.35% |
| 2021 FY | -6.51 Million CNY | 93.19% |
| 2021 Q3 | -28.12 Million CNY | -50.07% |
| 2020 Q2 | -61.12 Million CNY | -637.25% |
| 2020 FY | -95.73 Million CNY | 6.74% |
| 2020 Q4 | -396.29 Million CNY | -1044.44% |
| 2020 Q3 | -34.62 Million CNY | 43.35% |
| 2020 Q1 | -8.29 Million CNY | 94.84% |
| 2019 Q4 | -160.82 Million CNY | -127.31% |
| 2019 Q3 | -70.75 Million CNY | -1196.28% |
| 2019 Q2 | -5.45 Million CNY | -133.06% |
| 2019 Q1 | 16.5 Million CNY | 115.82% |
| 2019 FY | -102.65 Million CNY | -206.24% |
| 2018 Q2 | 52.96 Million CNY | -32.38% |
| 2018 Q3 | 33.66 Million CNY | -36.44% |
| 2018 Q4 | -104.37 Million CNY | -410.06% |
| 2018 FY | 96.62 Million CNY | -68.79% |
| 2018 Q1 | 78.32 Million CNY | -31.22% |
| 2017 Q1 | 62.26 Million CNY | -23.12% |
| 2017 FY | 309.64 Million CNY | 29.74% |
| 2017 Q4 | 113.88 Million CNY | 65.04% |
| 2017 Q3 | 69 Million CNY | 7.0% |
| 2017 Q2 | 64.49 Million CNY | 3.57% |
| 2016 Q3 | 58.5 Million CNY | 33.37% |
| 2016 FY | 238.66 Million CNY | 15.34% |
| 2016 Q4 | 80.99 Million CNY | 38.43% |
| 2016 Q2 | 43.87 Million CNY | -20.64% |
| 2016 Q1 | 55.28 Million CNY | 0.0% |
| 2015 FY | 206.92 Million CNY | 19.37% |
| 2014 FY | 173.34 Million CNY | 15.84% |
| 2013 FY | 149.63 Million CNY | 38.97% |
| 2012 FY | 107.67 Million CNY | 0.0% |